Creat membership Creat membership
Sign in

Forgot password?

  • Forgot password?
    Sign Up
  • Confirm
    Sign In
home > search

Now showing items 1 - 16 of 1504

  • Cutting Edge: Slamf8 Is a Negative Regulator of Nox2 Activity in Macrophages

    Wang, Guoxing   Abadia-Molina, Ana C.   Berger, Scott B.   Romero, Xavier   O'Keeffe, Michael S.   Rojas-Barros, Domingo I.   Aleman, Marta   Liao, Gongxian   Maganto-Garcia, Elena   Fresno, Manuel   Wang, Ninghai   Detre, Cynthia  

    Slamf8 (CD353) is a cell surface receptor that is expressed upon activation of macrophages (MFs) by IFN-g or bacteria. In this article, we report that a very high NADPH oxidase (Nox2) enzyme activity was found in Slamf8(-/-) MFs in response to Escherichia coli or Staphylococcus aureus, as well as to PMA. The elevated Nox2 activity in Slamf8(-/-) MFs was also demonstrated in E. coli or S. aureus phagosomes by using a pH indicator system and was further confirmed by a reduction in the enzyme activity after transfection of the receptor into Slamf8-deficient primary MFs or RAW 264.7 cells. Upon exposure to bacteria or PMA, protein kinase C activity in Slamf8(-/-) MFs is increased. This results in an enhanced phosphorylation of p40phox, one key component of the Nox2 enzyme complex, which, in turn, leads to greater Nox2 activity. Taken together, the data show that, in response to inflammation-associated stimuli, the inducible receptor Slamf8 negatively regulates inflammatory responses. The Journal of Immunology, 2012, 188: 5829-5832.
    Download Collect
  • A novel isoform of the Ly108 gene ameliorates murine lupus

    Detre, Cynthia   Rietdijk, Svend T.   Munoz, Pilar   Romero, Xavier   Berger, Scott B.   Calpe, Silvia   Liao, Gongxian   Castro, Wilson   Julien, Aimee   Wu, Ying-Yu   Shin, Dong-Mi   Sancho, Jaime   Zubiaur, Mercedes   Morse, Herbert C., III   Morel, Laurence   Engel, Pablo   Wang, Ninghai  

    Studies of human systemic lupus erythematosus patients and of murine congenic mouse strains associate genes in a DNA segment on chromosome 1 with a genetic predisposition for this disease. The systematic analysis of lupus-prone congenic mouse strains suggests a role for two isoforms of the Ly108 receptor in the pathogenesis of the disease. In this study, we demonstrate that Ly108 is involved in the pathogenesis of lupus-related auto-immunity in mice. More importantly, we identified a third protein isoform, Ly108-H1, which is absent in two lupus-prone congenic animals. Introduction of an Ly108-H1-expressing transgene markedly diminishes T cell-dependent autoimmunity in congenic B6.Sle1b mice. Thus, an immune response-suppressing isoform of Ly108 can regulate the pathogenesis of lupus.
    Download Collect
  • Signaling Lymphocyte Activation Molecule Regulates Development of Colitis in Mice

    van Driel, Boaz   Liao, Gongxian   Romero, Xavier   O'Keeffe, Michael S.   Wang, Guoxing   Faubion, William A.   Berger, Scott B.   Magelky, Erica M.   Manocha, Monika   Azcutia, Veronica   Grisham, Matthew   Luscinskas, Francis W.   Mizoguchi, Emiko   Malefyt, Rene de Waal   Reinecker, Hans-Christian   Bhan, Atul K.   Wang, Ninghai   Terhorst, Cox  

    BACKGROUND & AIMS: Signaling lymphocyte activation molecule (Slamf) 1 is a co-stimulatory receptor on T cells and regulates cytokine production by macrophages and dendritic cells. Slamf1 regulates microbicidal mechanisms in macrophages, therefore we investigated whether the receptor affects development of colitis in mice. METHODS: We transferred CD45RB(hi) CD4(+) T cells into Rag(-/-) or Slamf1(-/-) Rag(-/-) mice to induce colitis. We also induced colitis by injecting mice with an antibody that activates CD40. We determined the severity of enterocolitis based on disease activity index, histology scores, and levels of cytokine production, and assessed the effects of antibodies against Slamf1 on colitis induction. We quantified migration of monocytes and macrophage to inflamed tissues upon induction of colitis or thioglycollate-induced peritonitis and in response to tumor necrosis factor-alpha in an air-pouch model of leukocyte migration. RESULTS: Colitis was reduced in Slamf1(-/-) Rag(-/-) mice, compared with Rag(-/-) mice, after transfer of CD45RB(hi) CD4 broken vertical bar T cells or administration of the CD40 agonist. The numbers of monocytes and macrophages were reduced in inflamed tissues of Slamf1(-/-) Rag(-/-) mice, compared with Rag(-/-) mice, after induction of colitis and other inflammatory disorders. An antibody that inhibited Slamf1 reduced the level of enterocolitis in Rag(-/-) mice. CONCLUSIONS: Slamf1 contributes to the development of colitis in mice. It appears to indirectly regulate the appearance of monocytes and macrophages in inflamed intestinal tissues. Antibodies that inhibit Slamf1 reduce colitis in mice, so human SLAMF1 might be a therapeutic target for inflammatory bowel disease.
    Download Collect
  • The SLAM and SAP gene families control innate and adaptive immune responses

    Calpe, Silvia   Wang, Ninghai   Romero, Xavier   Berger, Scott B.   Lanyi, Arpad   Engel, Pablo   Terhorst, Cox  

    The nine SLAM-family genes, SLAMF1-9, a subfamily of the immunoglobulin superfamily, encode differentially expressed cell-surface receptors of hematopoietic cells. Engagement with their ligands, which are predominantly homotypic, leads to distinct signal transduction events, for instance those that occur in the T or NK cell immune synapse. Upon phosphorylation of one or more copies of a unique tyrosine-based signaling motif in their cytoplasmic tails, six of the SLAM receptors recruit the highly specific single SH2-domain adapters SLAM-associated protein (SAP), EAT-2A, and/or EAT-2B. These adapters in turn bind to the tyrosine kinase Fyn and/or other protein tyrosine kinases connecting the receptors to signal transduction networks. Individuals deficient in the SAP gene, SH2D1A, develop an immunodeficiency syndrome: X-linked lympho-proliferative disease. In addition to operating in the immune synapse, SLAM receptors initiate or partake in multiple effector functions of hematopoietic cells, for example, neutrophil and macrophage killing and platelet aggregation. Here we discuss the current understanding of the structure and function of these recently discovered receptors and adapter molecules in the regulation of adaptive and innate immune responses.
    Download Collect
  • Caspase-8 Collaborates with Caspase-11 to Drive Tissue Damage and Execution of Endotoxic Shock

    Manda, Pratyusha   Feng, Yanjun   Lyons, John D.   Berger, Scott B.   Otani, Shunsuke   DeLaney, Alexandra   Tharp, Gregory K.   Maner-Smith, Kristal   Burd, Eileen M.   Schaeffer, Michelle   Hoffman, Sandra   Capriotti, Carol   Roback, Linda   Young, Cedrick B.   Liang, Zhe   Ortlund, Eric A.   DiPaolo, Nelson C.   Bosinger, Steven   Bertin, John   Gough, Peter J.   Brodsky, Igor E.   Coopersmith, Craig M.   Shayakhmetov, Dmitry M.   Mocarski, Edward S.  

    The execution of shock following high dose E. coli lipopolysaccharide (LPS) or bacterial sepsis in mice required pro-apoptotic caspase-8 in addition to pro-pyroptotic caspase-11 and gasdermin D. Hematopoietic cells produced MyD88- and TRIF-dependent inflammatory cytokines sufficient to initiate shock without any contribution from cas pase-8 or caspase-11. Both proteases had to be present to support tumor necrosis factor- and interferon-beta-dependent tissue injury first observed in the small intestine and later in spleen and thymus. Caspase-11 enhanced the activation of caspase-8 and extrinsic cell death machinery within the lower small intestine. Neither caspase-8 nor caspase-11 was individually sufficient for shock. Both caspases collaborated to amplify inflammatory signals associated with tissue damage. Therefore, combined pyroptotic and apoptotic signaling mediated endotoxemia independently of RIPK1 kinase activity and RIPK3 function. These observations bring to light the relevance of tissue compartmentalization to disease processes in vivo where cytokines act in parallel to execute diverse cell death pathways.
    Download Collect
  • RIPK1-dependent apoptosis bypasses pathogen blockade of innate signaling to promote immune defense

    Peterson, Lance W.   Philip, Naomi H.   DeLaney, Alexandra   Wynosky-Dolfi, Meghan A.   Asklof, Kendra   Gray, Falon   Choa, Ruth   Bjanes, Elisabet   Buza, Elisabeth L.   Hu, Baofeng   Dillon, Christopher P.   Green, Douglas R.   Berger, Scott B.   Gough, Peter J.   Bertin, John   Brodsky, Igor E.  

    Many pathogens deliver virulence factors or effectors into host cells in order to evade host defenses and establish infection. Although such effector proteins disrupt critical cellular signaling pathways, they also trigger specific antipathogen responses, a process termed "effector-triggered immunity." The Gram-negative bacterial pathogen Yersinia inactivates critical proteins of the NF-kappa B and MAPK signaling cascade, thereby blocking inflammatory cytokine production but also inducing apoptosis. Yersinia-induced apoptosis requires the kinase activity of receptor-interacting protein kinase 1 (RIPK1), a key regulator of cell death, NF-kappa B, and MAPK signaling. Through the targeted disruption of RIPK1 kinase activity, which selectively disrupts RIPK1-dependent cell death, we now reveal that Yersinia-induced apoptosis is critical for host survival, containment of bacteria in granulomas, and control of bacterial burdens in vivo. We demonstrate that this apoptotic response provides a cell-extrinsic signal that promotes optimal innate immune cytokine production and antibacterial defense, demonstrating a novel role for RIPK1 kinase-induced apoptosis in mediating effector-triggered immunity to circumvent pathogen inhibition of immune signaling.
    Download Collect
  • CD43-independent augmentation of mouse T-cell function by glycoprotein cleaving enzymes

    Berger, Scott B.   Akha, Amir A. Sadighi   Miller, Richard A.   Garcia, Gonzalo G.  

    Previous work has shown that the function of mouse CD4(+) T cells can be augmented by an enzyme, O-sialoglycoprotein endopeptidase (OSGE), which cleaves surface CD43, suggesting the idea that the high levels of glycosylated CD43 found on T cells from aged mice may contribute to immune senescence. New results now show that OSGE improves T-cell function even in mice lacking CD43, showing that other glycoproteins must contribute to the OSGE effect on function. Evaluation of other enzymes found two whose ability to stimulate CD4 activation was higher in aged than in young T cells. One of these, PNGase F, is a glycosidase specific for N-linked glycans, and the other, ST-Siase(2,3) from Salmonella typhimurium, is specific for alpha 2,3-linked terminal sialic acid residues. Parallel lectin-binding experiments showed that removal of alpha 2,3-linked sialic acid residues vulnerable to PNGase F and ST-Siase(2,3) was also greater in old than in young T cells. The preferential ability of PNGase F and ST-Siase(2,3) to improve the function of T cells from aged mice may involve cleavage of glycoproteins containing alpha 2,3-linked sialic acid residues on N-linked or O-linked glycans or both.
    Download Collect
  • Enhancement of CD8 T-cell function through modifying surface glycoproteins in young and old mice

    Akha, Amir A. Sadighi   Berger, Scott B.   Miller, Richard A.  

    Previous work from our laboratory has shown that modifying cell surface glycosylation with either a Clostridium perfringens-derived sialidase (CP-Siase), or an O-linked glycoprotein endopeptidase (OSGE) can enhance the function of CD4 T cells from both young and old mice at multiple levels. Here we have re-assessed the effect of age on CD8 T-cell function, and examined the outcome of enzymatic treatment with CP-Siase and OSGE on its different aspects. Pre-treatment of CD8 T cells with either CP-Siase or OSGE led to a significant increase in anti-CD3-mediated Ca(2+) response in both young and old mice. Pre-treated CD8 T cells from both age groups also displayed a significant increase in activation-induced CD69 and CD25 expression, and produced significantly higher amounts of interleukin-2 and interferon-gamma in comparison to their untreated counterparts. Furthermore, pretreatment with either enzyme enhanced granzyme B expression in CD8 T cells, and increased their cytolytic activity in vitro. These data support the notion that glycosylated surface proteins hinder CD8 T-cell activation and function in both young and old mice, and raise the possibility of significantly improving CD8 T cell function in older individuals through enzymatic alteration of surface glycoproteins.
    Download Collect
  • Identification of a RIP1 Kinase Inhibitor Clinical Candidate (GSK3145095) for the Treatment of Pancreatic Cancer

    Harris, Philip A.   Marinis, Jill M.   Lich, John D   Berger, Scott B.   Chirala, Anirudh   Cox, Julie A   Eidam, Patrick M   Finger, Joshua N.   Gough, Peter J.   Jeong, Jae U   Kang, James   Kasparcova, Viera   Leister, Lara K   Mahajan, Mukesh K.   Miller, George   Nagilla, Rakesh   Ouellette, Michael T.   Reilly, Michael A.   Rendina, Alan R.   Rivera, Elizabeth J.   Sun, Helen H.   Thorpe, James H.   Totoritis, Rachel D   Wang, Wei   Wu, Dongling   Zhang, Daohua   Bertin, John   Marquis, Robert W  

    Download Collect
  • Frameless Laser-Guided Stereotaxis: A System for CT-Monitored Neurosurgical Interventions

    Hussman, Karl L.   Chaloupka, John C.   Berger, Scott B.   Chon, Kenneth S.   Broderick, Maggie  

    Download Collect
  • Receptor-interacting protein 1 kinase inhibition therapeutically ameliorates experimental T cell-dependent colitis in mice

    Gobbetti, Thomas   Berger, Scott B.   Fountain, Kathryn   Slocombe, Tom   Rowles, Alison   Pearse, Gail   Harada, Isobel   Bertin, John   Haynes, Andrea C.   Beal, Allison M.  

    Download Collect
  • GITR engagement preferentially enhances proliferation of functionally competent CD4(+)CD25(+)FoxP3(+) regulatory T cells

    Nayak, Sushrusha   Regueiro, Jose R.   Berger, Scott B.   Detre, Cynthia   Romero, Xavier   Malefyt, Rene de Waal   Chatila, Talal A.   Herzog, Roland W.   Terhorst, Cox  

    Naturally occurring regulatory T cells (Treg) express high levels of glucocorticoid-induced tumour necrosis factor receptor (GITR). However, studies of the role of GITR in Treg biology has been complicated by the observation that upon activation effector CD4(+) T (Ten) cells also express the receptor. Here, we dissect the contribution of GITR-induced signaling networks in the expansion and function of FoxP3(+) Treg. We demonstrate that a high-affinity soluble Fc-GITR-L dimer, in conjugation with alpha CD3, specifically enhances in vitro proliferation of Treg, which retain their phenotypic markers (CD25 and FoxP3) and their suppressor function, while minimally affecting Teff cells. Furthermore, Fc-GITR-L does not impair Teff susceptibility to suppression, as judged by cocultures employing GITR-deficient and GITR-sufficient CD4(+) T-cell subsets. Notably, this expansion of Treg could also be seen in vivo, by injecting FoxP3-IRES-GFP mice with Fc-GITR-L even in the absence of antigenic stimulation. In order to test the efficacy of these findings therapeutically, we made use of a C3H/HeJ hemophilia B-prone mouse model. The use of liver-targeted human coagulation factor IX (hF.IX) gene therapy in this model has been shown to induce liver toxicity and the subsequent failure of hF.IX expression. Interestingly, injection of Fc-GITR-L into the hemophilia-prone mice that were undergoing liver-targeted hF.IX gene therapy increased the expression of F.IX and reduced the anticoagulation factors. We conclude that GITR engagement enhances Treg proliferation both in vitro and in vivo and that Fc-GITR-L may be a useful tool for in vivo tolerance induction.
    Download Collect
  • Glucocorticoid-Induced Tumor Necrosis Factor Receptor Family-Related Protein Regulates CD4(+)T Cell-Mediated Colitis in Mice

    Liao, Gongxian   Detre, Cynthia   Berger, Scott B.   Engel, Pablo   Malefyt, Rene de Waal   Herzog, Roland W.   Bhan, Atul K.   Terhorst, Cox  

    BACKGROUND & AIMS: The glucocorticoid-induced tumor necrosis factor receptor family-related protein (GITR; also called TNFRSF18 or CD357) regulates the T cell-mediated immune response and is present on surfaces of regulatory T (Treg) cells and activated CD4(+) T cells. We investigated the roles of GITR in the development of colitis in mice. METHODS: Chronic enterocolitis was induced by the transfer of wild-type or GITR(-/-) CD4(+) T cells to GITR(-/-) x Rag(-/-) or Rag(-/-) mice. We determined the severity of colitis by using the disease activity index; measured levels of inflammatory cytokines, T cells, and dendritic cells; and performed histologic analysis of colon samples. RESULTS: Transfer of nonfractionated CD4(+) cells from wild-type or GITR(-/-) donors induced colitis in GITR(-/-) x Rag(-/-) but not in Rag(-/-) mice. Among mice with transfer-induced colitis, the percentage of Treg and T-helper (Th) 17 cells was reduced but that of Th1 cells increased. Treg cells failed to prevent colitis in GITR(-/-) x Rag(-/-) recipients; this was not the result of aberrant function of GITR(-/-) Treg or T effector cells but resulted from an imbalance between the numbers of tolerogenic CD103(+) and PDCA1(+) plasmacytoid dendritic cells in GITR(-/-) mice. This imbalance impaired Treg cell development and expanded the Th1 population in GITR(-/-) x Rag(-/-) mice following transfer of nonfractionated CD4(+) cells. CONCLUSIONS: GITR is not required on the surface of Treg and T effector cells to induce colitis in mice; interactions between GITR and its ligand are not required for induction of colitis. GITR instead appears to control dendritic cell and monocyte development; in its absence, mice develop aggravated chronic enterocolitis via an imbalance of colitogenic Th1 cells and Treg cells.
    Download Collect
  • T Cell– and Monocyte-Specific RNA-Sequencing Analysis in Septic and Nonseptic Critically Ill Patients and in Patients with Cancer

    Washburn, Michael L.   Wang, Zhang   Walton, Andrew H.   Goedegebuure, S. Peter   Figueroa, David J.   Van Horn, Stephanie   Grossman, Julie   Remlinger, Katja   Madsen, Heather   Brown, James   Srinivasan, Roopa   Wolf, Amaya I.   Berger, Scott B.   Yi, Victoria N.   Hawkins, William G.   Fields, Ryan C.   Hotchkiss, Richard S.  

    Download Collect

    Hawkes, A. D.   Lipps, J. H.  

    Download Collect

    Hawkes, A. D.; Lipps, J. H.  

    Download Collect
1 2 3 4 5 6 7 8 9 10


If you have any feedback, Please follow the official account to submit feedback.

Turn on your phone and scan

Submit Feedback